German Gynecological Oncology Group (AGO) Recognizes BluePrint® in Breast Cancer Guidelines lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Data from the NeoDynamics PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies..